跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
捷灵亚 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fingolimod Hydrochloride Capsules
Approved
化学药品
Fingolimod Hydrochloride Capsules
Novartis Pharma Schweiz AG
🇨🇳 National Medical Products Administration
Approval Date
Sep 27, 2019
Approval ID
7uctHO4PpUC
Company
Novartis Pharma Schweiz AG
Type
化学药品
Approval Details
Approval Id
7uctHO4PpUC
Approval Number
国药准字J20190024
Generic Name
盐酸芬戈莫德胶囊
Generic Name En
Fingolimod Hydrochloride Capsules
Trade Name
捷灵亚
Brand Name
捷灵亚
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.5mg(按C19H33NO2计)
Reg Date
2019-09-27
Company Name
Novartis Pharma Schweiz AG
Company Address
6343 Risch, Switzerland
Production Company Name
Novartis Pharma Stein AG
Production Company Address
Schaffhauserstrasse 4332 Stein,Switzerland
Company Detail Path
/organization/novartis-pharma-schweiz-ag
Production Company Detail Path
/organization/novartis-pharma-stein-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 27, 2019
Approval ID
7uctHO4PpUC
Type
化学药品
Back to NMPA Approvals